approximately one-third of all deaths (17 million) were attributable to cardiovascular disease-a 35% increase since 1990. 8 This trend is likely to continue as more human beings are shielded from the early deaths due to infectious diseases and extreme poverty. Globally, cardiovascular diseases are afflicting ever-increasing numbers of young-and middle-aged adults. This is especially so in low-and middle-income countries that are faced with the double burden of communicable and non-communicable diseases to which cardiovascular illnesses contribute significantly. 9 Nearly 80% of the world's more than 1 billion smokers live in low-and middle-income countries. 10 Respectively, ischaemic heart disease and stroke are responsible for the 1st and 3rd highest numbers of years of life lost and disability-adjusted life years worldwide, replacing childhood conditions from 1990 to 2010.
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In addition to such a significant burden of mortality and morbidity, cardiovascular diseases face important quality challenges that extend beyond the traditional boundaries of medical science and practice. For example, there are substantial and quantifiable equity issues: cardiovascular mortality is higher in people with low education, income, social class or those in marginalized ethnic groups, and those living in poor and deprived communities.
9 There are also complex behavioural issues: patients rarely adhere to their medications, and there is a significant decline in the use of medications after treatment initiation. 12 Finally, access to best care often requires complex infrastructures-including interventional and surgical services, for which best care models need to be constantly refined. As a result, a large proportion of individuals have cardiovascular risk factors that remain uncontrolled despite the availability of proven, effective, and often inexpensive therapies, and large patient populations are deprived of evidence-based care.
13
Economic, workforce-related, and political challenges around the world are straining government budgets, and putting unprecedented pressure on health care delivery systems. Currently, the quality of cardiovascular care delivery remains sub-optimal even in some of the richest parts of the world.
14 There is now a chasm between what
should happen versus what does happen in health care systems. Despite the recent emergence of health technology assessment and clinical practice guideline development efforts over the past decades, observed differences between evidence-based recommendations and their implementation-the so-called evidence-practice gapsare widespread. 15 While health care systems heavily invest in efforts to ensure appropriate provision and use of technologies and services, under-use and over-use problems continue to co-exist side-byside. 16 There is both a lack of implementation of some proven effective strategies, and also inappropriate use of strategies with strong evidence against, or insufficient evidence for their effectiveness and safety.
A new future in cardiovascular medicine
Tackling these challenges is not straightforward and warrants innovative policy and management responses. A new generation of leaders from within the profession can devise creative solutions and transform the future of cardiovascular medicine. Key insights from social and behavioural sciences can help towards this goal. Over the past decades, cardiovascular medicine has served as an incubator for developing and testing innovative policy mechanisms in health care such as pay-for-performance. 17 This is perhaps unsurprising as several cardiovascular outcomes are relatively easy to capture in routinely collected administrative databases and thus amenable to monitoring, measurement, and accountability. In fact, many quality improvement interventions that are commonplace today (e.g. public reporting of outcome data) were first developed, tested, and subsequently rolled out in cardiovascular medicine.
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The reach of policy and economics in cardiovascular medicine is far and wide. 19 As new innovative medical and surgical interventions are approved or adopted, their affordability is almost as widely discussed and debated as their health benefits and safety. Questions to which the fields of health policy and economics can help answer are several and include:
• How are funds collected, pooled, and allocated in health care systems?
• What are the implications of different health financing mechanisms?
• What are the advantages and disadvantages of the current processes for medical technology approval and reimbursement?
• Which population sub-groups are eligible to receive care and at what cost?
• What type of evidence is used to inform practice guidelines and quality indicators that increasingly form the basis of physician compensation?
As an increasing number of countries experiment with new policy mechanisms aimed at improving quality and access, and containing costs, cardiovascular experts are best suited to join forces with health services researchers, managers, economists, and policymakers to inform the design, implementation, and evaluation of future interventions. An interdisciplinary training program can help ensure that stakeholders from different perspectives and backgrounds adopt a common language when discussing current issues and considering alternative solutions.
An innovative program for future leaders in cardiovascular medicine
The European Heart Academy (EHA) of the European Society of Cardiology has joined forces with the London School of Economics and Political Science (LSE), a global leader in social sciences research and teaching, to develop and deliver a unique Master's degree program on health economics, policy, and outcomes research aimed at health care professionals in cardiovascular sciences with full-time employment (Box 1).
Currently in its 3rd year, the master's level program has already trained 80 cardiovascular specialists from over 20 countries. The program has a carefully crafted curriculum to ensure that health care professionals in the cardiovascular medicine field gain a complementary set of skills to their specialized training in clinical medicine. In addition to compulsory courses focused on quality, economics, and policy, a range of optional modules tackle not only today's challenges like management and health technology assessment but also tomorrow's opportunities such as behavioural science and performance measurement in a fast-changing health care environment ( Table 1) .
With advanced training in outcomes research, policy, and health economics, course participants leave the program equipped with key skills to become the future champions of policy and management • The vision behind the program was to equip cardiovascular specialists with essential research and policy skills to make active contributors to health policy discussions.
• To implement this vision, a working group was immediately formed and included Huseyin Naci and Paulus Kirchhof in addition to Panos Vardas and Elias Mossialos.
• The working group collaborated on designing a curriculum and establishing an innovative set of modules and assessments.
• Following the program's successful launch in December 2015 with its first intake of 39 students, a Steering Committee was formed to mon- • In its first 2 years, the program has attracted high-profile speakers including Jeroen Bax (President of ESC), Professor Sir Julian LeGrand (Former Senior Advisor to Tony Blair), Leeza Osipenko (Director of Scientific Advice, National Institute for Health and Care Excellence), Dr Matt Kearney (National Clinical Director for Cardiovascular Disease Prevention, NHS England), and Professor Tony Rudd (National Clinical Director for Stroke, NHS England). change in their clinics, hospitals, national and regional health systems, regulatory authorities, and even at the world stage. An expanding network of graduates are expected to take on roles in guideline development panels, health technology assessment committees, publicprivate research initiatives, consulting companies, and pharmaceutical, medical device, biotech, and big data and data analytics industries.
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Conclusion
As health care costs continue to rise, cardiovascular medicine will undisputedly come under greater scrutiny over the next decade. London School of Economics and Political Science's inter-disciplinary post-graduate training program developed in collaboration with the ESC is aimed at equipping health care professionals within cardiovascular medicine with a highly relevant skillset in social sciences. With such training, researchers, and practitioners from within the profession have an opportunity to become active voices and role models in discussions that affect every corner of medicine and its practice. Quality and outcomes in cardiovascular sciences
• Provides an overview of the concept of quality, its key components, and its measurement in different health care systems.
• Offers a critical perspective on the literature evaluating quality improvement interventions focused on the cardiovascular disease field.
Measuring health system performance
• Presents a framework to discuss the opportunities and challenges with performance measurement in health care.
• Focuses on the measurement instruments and analytic tools needed for performance measurement.
Economic analysis for health policy
• Serves as an introduction to major developments in the economics of health and health care.
• Provides health care professionals with a strong understanding of the role economics can play in health policy and health system administration Financing health care
• Gives a thorough grounding in health financing policy.
• Focuses on the health financing functions of collecting revenue, pooling funds and purchasing services, as well as on policy choices concerning coverage, resource allocation and provider payment mechanisms.
Systematic review and meta-analysis
• Covers the principles of reviewing and synthesizing the existing body of literature.
• Provides an overview of methods for quantitatively synthesizing multiple randomized controlled trials in meta-analysis.
Research design for evaluating health programs and policies
• Provides a practical overview of the principles and models of evaluation, and the role of theories, concepts, and hypotheses.
• Covers study design choices in light of bias, validity and other design trade-offs.
Economic evaluation in health care
• Focuses on analytic methods in the economic evaluation of health interventions.
• Provides a strong foundation in cost-effectiveness analysis of interventions used in long-term chronic illnesses.
Behavioural science for health
• Introduces the main tools and principles of behavioural sciences and the key state-of-the-art applications to health economics, policy, and management.
• Applies behavioural science tools to concrete challenges in the health area.
Using health economics to analyse and inform policy and practice
• Gives an overview on how health systems are constructed, and how the various parts of the system interact.
• Focuses on the role of regulation, resource allocation, payment arrangements, and the complexities of evaluating policy and performance.
Principles of health technology assessment
• Introduces the role of Health Technology Assessment in health care reimbursement and coverage decision making.
• Covers the key operational modalities of health technology assessment, the different models of value assessment and how they link to decisionmaking.
Dissertation
• Offers an opportunity to carry out independent study.
• Integrates approaches and knowledge learned across courses and present results to address a health/clinical policy.
Introduction to management in health care
• Introduces the main principles of management and strategy and related issues that impact on organisational change, group decision making, innovation and leadership.
• Applies academic management knowledge to health care practice.
